07:04 AM EST, 03/05/2024 (MT Newswires) -- Apogee Therapeutics ( APGE ) reported a Q4 net loss Tuesday of $31.7 million, widening from its $14.0 million net loss a year earlier.

Analysts polled by Capital IQ expected a net loss of $27.1 million.

As expected, no revenue for the quarter ended Dec. 31, was reported.

As of Dec. 31, the company said it had total cash of $395.5 million, and expected it could fund operations through 4Q 2026.

Price: 43, Change: +1.26, Percent Change: +3.02